Cargando…
STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557450/ https://www.ncbi.nlm.nih.gov/pubmed/32725123 http://dx.doi.org/10.1093/eurheartj/ehaa520 |
| _version_ | 1783594423345479680 |
|---|---|
| author | Wang, Si Wei, Xin Hu, Hongde |
| author_facet | Wang, Si Wei, Xin Hu, Hongde |
| author_sort | Wang, Si |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7557450 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-75574502020-10-20 STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk Wang, Si Wei, Xin Hu, Hongde Eur Heart J Discussion Forum Oxford University Press 2020-07-29 /pmc/articles/PMC7557450/ /pubmed/32725123 http://dx.doi.org/10.1093/eurheartj/ehaa520 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | Discussion Forum Wang, Si Wei, Xin Hu, Hongde STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title | STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title_full | STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title_fullStr | STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title_full_unstemmed | STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title_short | STAR evidence evaluation of viral fulminant myocarditis: Specificity, Timeliness, Accessibility, Risk |
| title_sort | star evidence evaluation of viral fulminant myocarditis: specificity, timeliness, accessibility, risk |
| topic | Discussion Forum |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557450/ https://www.ncbi.nlm.nih.gov/pubmed/32725123 http://dx.doi.org/10.1093/eurheartj/ehaa520 |
| work_keys_str_mv | AT wangsi starevidenceevaluationofviralfulminantmyocarditisspecificitytimelinessaccessibilityrisk AT weixin starevidenceevaluationofviralfulminantmyocarditisspecificitytimelinessaccessibilityrisk AT huhongde starevidenceevaluationofviralfulminantmyocarditisspecificitytimelinessaccessibilityrisk |